ANDERSONS files Form 144 to sell 2,500 shares

ANDERSONS, Inc. reported a proposed sale of 2,500 shares of Common Stock via Fidelity Brokerage Services LLC, with an aggregate reported value of $175,750.00.

Accepted by SEC EDGAR 03/17/2026 - 04:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ANDERSONS, Inc. reported a proposed sale of 2,500 shares of Common Stock via Fidelity Brokerage Services LLC, with an aggregate reported value of $175,750.00. The filing lists 33,880,130 shares outstanding as of 03/17/2026. The transactions are described as related to restricted stock vesting on multiple prior grant dates.

Insights

Corporate Governance Analyst

Routine Form 144 notice for vested restricted shares being sold through a broker.

The filing lists a proposed sale of $175,750.00 for 2,500 shares handled by Fidelity Brokerage Services LLC. The sale is tied to previously granted restricted stock vesting events dated between 03/01/2013 and 02/01/2019.

These notices are typically administrative; cash‑flow treatment and exact sale timing are not provided in the excerpt. Subsequent Form 4 or broker reports may show execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ANDE's Form 144 report?

The Form 144 reports a proposed sale of 2,500 shares of Common Stock valued at $175,750.00. It lists Fidelity Brokerage Services LLC as the broker and links the shares to prior restricted stock vesting events.

Who is the brokerage handling the proposed sale for ANDE?

The proposed sale is reported as to be handled by Fidelity Brokerage Services LLC. The filing does not provide further details about execution timing or sale method beyond the broker name.

How many ANDE shares outstanding are noted in the filing?

The filing shows 33,880,130 shares outstanding as of 03/17/2026. This figure is presented as a baseline in the excerpt and not as the amount being offered for sale.

Are the shares being sold newly issued or from vested awards?

The excerpt ties the reported shares to multiple prior restricted stock vesting dates (e.g., 03/01/2013, 05/16/2017). The entries indicate the shares derive from vested compensation awards.

Does the Form 144 specify when the sale will occur?

The Form 144 lists the proposed quantity and broker but does not specify the exact execution date or whether the sale has occurred. Execution details would appear in subsequent transaction reports.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001475163
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Andersons, Inc.
SEC File Number	000-20557
Address of Issuer	1947 BRIARFIELD BOULEVARD MAUMEE OHIO 43537
Phone	(419)893-5050
Name of Person for Whose Account the Securities are To Be Sold	Stout John T Jr
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2500	175750.00	33880130	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2013	Restricted Stock Vesting	Issuer			687	03/01/2013	Compensation
Common	05/16/2017	Restricted Stock Vesting	Issuer			221	05/16/2017	Compensation
Common	08/01/2017	Restricted Stock Vesting	Issuer			218	08/01/2017	Compensation
Common	02/01/2018	Restricted Stock Vesting	Issuer			220	02/01/2018	Compensation
Common	03/02/2018	Restricted Stock Vesting	Issuer			727	03/02/2018	Compensation
Common	08/01/2018	Restricted Stock Vesting	Issuer			213	08/01/2018	Compensation
Common	02/01/2019	Restricted Stock Vesting	Issuer			214	02/01/2019	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John T. Stout Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)